Education & Prevention

Professional training, workshops, and speaking on toxicology, scientific interpretation, and drug safety

Dr. Ruby Javed provides professional training, workshops, and speaking on forensic toxicology and drug-safety topics. These educational services help audiences understand scientific findings, recognize limitations, and ask informed questions about evidence and prevention.

The proposed audience, subject, level of detail, and format are discussed before an engagement. Educational content should distinguish general scientific principles from conclusions that require review of an individual person's circumstances or a particular case.

Education is not a substitute for medical treatment, legal advice, an independent case review, or an official testing-program determination. A presentation does not establish that a particular exposure occurred, that someone was impaired, or that a specific outcome can be prevented.

Who can inquire about toxicology education or a presentation?

Attorneys, laboratory teams, professional organizations, and other groups seeking education within Dr. Javed's expertise can use the Contact page to discuss a proposed engagement.

An inquiry should explain who will attend, what the audience needs to understand, and how the information will be used. The suitability of the topic and the scope of the presentation are assessed before arrangements are agreed.

A general educational session is different from reviewing evidence in a particular case. If the request involves a disputed result or an individual matter, a separate scientific consultation may be appropriate.

What subjects can a proposed session cover?

Depending on the audience and agreed scope, subjects may include:

  • How toxicology findings are interpreted in the context of other evidence.
  • Differences between detecting a substance and establishing impairment, toxicity, or causation.
  • Screening and definitive testing, testing-panel limitations, and reporting thresholds.
  • Specimen differences, collection timing, and common interpretation errors.
  • Prescription and over-the-counter medicines, alcohol interactions, and drug-safety awareness.
  • Clear communication of scientific findings, limitations, and uncertainty.

The subject matter should match the audience's needs and Dr. Javed's expertise. Listing a topic does not establish that a particular course, standardized curriculum, or certification program is available.

Can a workshop be tailored to the audience?

The proposed content can be discussed in relation to the audience's background, learning objectives, and available time. A technical discussion for laboratory professionals may require a different level of detail from an introductory presentation for another professional group.

The topic, format, duration, use of examples, and any requested supporting materials should be agreed in advance. Availability and suitability must be confirmed; an inquiry does not reserve a date or guarantee that every requested subject can be included.

Tailoring the educational content does not turn a workshop into a laboratory inspection, a compliance determination, or a substitute for a case-specific opinion.

What does drug-safety and prevention education address?

Education may address practical ways to recognize medication-related risks, understand labels and warnings, and know when to seek advice from a treating clinician or pharmacist.

Topics can include the potential effects of combining medicines or alcohol, the importance of checking active ingredients in multiple products, and the fact that a prescribed or legally available medicine may still affect alertness or driving.

These are general prevention principles, not a guarantee of safety or a personalized assessment. The effects and risks depend on the substance, dose, combinations, health conditions, and other individual circumstances.

Can a presentation tell someone which medicines are safe for them or when they can drive?

No. A general presentation cannot determine an individual's treatment, medication compatibility, fitness for duty, or ability to drive safely at a particular time.

Read the product's directions and warnings, and discuss prescription medicines, nonprescription products, supplements, and alcohol use with the treating clinician or pharmacist. Do not stop or change prescribed treatment based on a workshop or general website information.

Some prescription and over-the-counter medicines can impair driving, and combinations can increase risk. Do not drive if impaired or if the medicine's instructions or a treating professional advise against it. Attendance at an educational session is not clearance to drive or perform safety-sensitive work.

Does attending a session provide certification or continuing-education credit?

A presentation or workshop should not be assumed to provide professional certification, continuing-education credit, regulatory qualification, or authorization to perform a laboratory or testing-program role.

If an organizer needs a particular credit arrangement, attendance documentation, or other recognition, those requirements should be raised before an engagement. Any arrangement would need separate confirmation, including any approval required from the relevant organization.

No accredited credit, certification, or approval is advertised or promised by this FAQ.

Can real cases or participant examples be discussed?

Educational examples may help explain scientific principles, but confidentiality, permission, and the limits of the available information must be considered before using case material.

Do not include client identities, patient information, or confidential records in an initial presentation inquiry. Discuss any proposed use of case material and the appropriate arrangements before sharing it.

An example should not be presented as a complete assessment of another person's case. Discussion during a session does not automatically create a retained expert relationship or a case-specific scientific opinion.

How are fees and engagement arrangements handled?

Use the Contact page to describe the proposed event, and review the Pricing page for published consultation fees and engagement terms. The applicable scope, presentation fee, preparation, requested materials, and any travel arrangements should be confirmed for the particular engagement.

Do not assume that general consultation rates cover every presentation arrangement or that an introductory inquiry includes free training. Dates, availability, and any organizer requirements must be confirmed before making commitments.

An educational engagement does not promise a particular audience outcome, legal result, or reduction in incidents.

What information is useful when requesting a session?

An initial inquiry may include:

  • The organizer or organization and the purpose of the event.
  • The intended audience and approximate number of attendees.
  • The audience's professional background and existing familiarity with toxicology.
  • The preferred topic, questions to address, and learning objectives.
  • The proposed format and duration, including any requested discussion time.
  • Proposed dates and, where relevant, the event location or delivery arrangements.
  • Relevant accessibility needs and any organizer requirements.
  • Whether examples or supporting materials are requested, without sending confidential case information.
  • A contact person and any planning deadlines.

These details help assess suitability and define the proposed scope. They do not establish a confirmed booking or approval of a particular program.

This information and any general educational presentation are not medical treatment, legal advice, an official testing-program determination, or a case-specific scientific opinion. They do not certify competence, guarantee prevention of harm, or establish fitness for duty or driving. For an urgent medical concern, seek immediate medical care rather than waiting for an educational engagement or consulting review.

Scientific and educational references

U.S. Food and Drug Administration. Drug Interactions: What You Should Know.

Supports general education about drug-drug, drug-food or beverage, and drug-condition interactions; reading labels; duplicate active ingredients; and discussing medicines and supplements with a clinician or pharmacist.

National Highway Traffic Safety Administration. Dangers of Driving After Taking Prescription Drugs or Over-the-Counter Medicines.

Supports the explanation that prescription and nonprescription medicines can affect driving and that medication combinations or alcohol may increase impairment risk. It is not an individualized determination of driving ability.

ARUP Consult. Drug Testing. Last literature review December 2024; updated October 2026.

Supports the general testing topics concerning presumptive and definitive methods, specimen differences, detection limitations, and interpretation in context. It does not establish training accreditation or a universal workplace testing policy.

These references support general scientific and educational explanations. They do not imply endorsement of Dr. Javed, sponsorship of her presentations, continuing-education approval, or any certification. Educational content and any case-specific interpretation require the appropriate scope and context.

Use the Contact page to inquire about professional training, a workshop, or a speaking engagement on toxicology and drug safety. Describe the audience, topic, proposed timing, and any organizer requirements. Review the Pricing page for published fees and engagement terms, and confirm the arrangements applicable to the proposed event before making commitments.

Request a Consultation Pricing & Engagement